Document Type : Original Article


1 DVM Graduate, Faculty of Veterinary Medicine, Urmia Branch, Islamic Azad University, Urmia, Iran

2 Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia Branch, Islamic Azad University, Urmia, Iran

3 Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran


The precise pathophysiology of polycystic ovary syndrome (PCOS) is not well-founded. In an attempt to fill this gap, the current study was executed to probe the effect of nanocurcumin (NCC) on ovarian tissue, in vitro fertilization (IVF) and pre-implantation embryo development in a mouse model of PCOS. Fifty adult female mice were randomly categorized into five equal groups including non-treated control and PCOS (receiving 0.20 mg estradiol valerate (EV) intra-peritoneally once a day for 21 days) as well as NCC12.50 + PCOS, NCC25 + PCOS and NCC50 + PCOS (receiving respectively 12.50, 25.00 and 50.00 mg kg-1 NCC daily along with EV injection through oral gavages for 21 days) groups. Subsequently, ovarian histo-architecture and total anti-oxidant capacity, and malonaldehyde and catalase levels as well as in vitro fertilizing potential, early embryonic development and serum testosterone concentration were analyzed. Results showed that NCC in a dose-dependent manner improved ovarian cyto-architectural organization and oxidant/anti-oxidant balance along with IVF rate and pre-implantation embryo development in PCOS mice. These findings revealed that NCC at the doses of 25.00 and 50.00 mg kg-1 could alleviate PCOS-linked reproductive disruptions in female mice.


Main Subjects

  1. Sadeghi HM, Adeli I, Calina D, et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci 2022; 23(2): 583. doi: 10.3390/ijms23020583.
  2. Zuo M, Liao G, Zhang W, et al. Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring. J Ovarian Res 2021; 14(1): 15. doi: 10.1186/s13048-020-00755-z.
  3. Venegas B, De León Gordillo LY, Rosas G, et al. In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation. Reprod Biol Endocrinol 2019; 17(1): 95. doi: 10.1186/s12958-019-0539-y.
  4. Ganie MA, Vasudevan V, Wani IA, et al. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res 2019; 150(4): 333-344.
  5. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 2018; 14(5): 270-284.
  6. Radmanesh F, Razi M, Shalizar-Jalali A. Curcumin nano-micelle induced testicular toxicity in healthy rats; evidence for oxidative stress and failed homeostatic response by heat shock proteins 70-2a and 90. Biomed Pharmacother 2021; 142: 111945. doi: 10.1016/j. biopha.2021.111945.
  7. Yan Z, Dai Y, Fu H, et al. Curcumin exerts a protective effect against premature ovarian failure in mice. J Mol Endocrinol 2018; 60(3): 261-271.
  8. Sak ME, Soydinc HE, Sak S, et al. The protective effect of curcumin on ischemia-reperfusion injury in rat ovary. Int J Surg 2013; 11(9): 967-970.
  9. Bachmeier BE, Mirisola V, Romeo F, et al. Reference profile correlation reveals estrogen-like trancriptional activity of curcumin. Cell Physiol Biochem 2010; 26(3): 471-482.
  10. Karthikeyan A, Senthil N, Min T. Nanocurcumin: a promising candidate for therapeutic applications. Front Pharmacol 2020; 11: 487. doi: 10.3389/fphar. 2020.00487.
  11. Abuelezz NZ, Shabana ME, Rashed L, et al. Nanocurcumin modulates miR-223-3p and NF-κB levels in the pancreas of rat model of polycystic ovary syndrome to attenuate autophagy flare, insulin resistance and improve ß cell mass. J Exp Pharmacol 2021; 13: 873-888.
  12. Kokabiyan Z, Yaghmaei P, Jameie SB, et al. Therapeutic effects of eugenol in polycystic ovarian rats induced by estradiol valerate: a histopathological and a bio-chemical study. Int J Fertil Steril 2022; 16(3): 184-191.
  13. Abdel-Azeem AM, Abdel-Rehiem ES, Farghali AA, et al. Ameliorative role of nanocurcumin against the toxicological effects of novel forms of Cuo as nanopesticides: a comparative study. Environ Sci Pollut Res Int 2023; 30(10): 26270-26291.
  14. Azad F, Nejati V, Shalizar-Jalali A, et al. Antioxidant and anti-apoptotic effects of royal jelly against nicotine-induced testicular injury in mice. Environ Toxicol 2019; 34(6): 708-718.
  15. Tappel AL, Zalkin H. Inhibition of lipid peroxidation in mitochondria by vitamin E. Arch Biochem Biophys 1959; 80(2): 333-336.
  16. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
  17. Katalinic V, Modun D, Music I, et al. Gender differences in antioxidant capacity of rat tissues determined by 2, 20-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays. Comp Biochem Physiol C Toxicol Pharmacol 2005; 140(1): 47-52.
  18. Azad F, Nejati V, Shalizar-Jalali A, et al. Royal jelly protects male mice against nicotine-induced repro-ductive failure. Vet Res Forum 2018; 9(3): 231-238.
  19. Nourian A, Soleimanzadeh A, Shalizar-Jalali A, et al. Effects of bisphenol-S low concentrations on oxidative stress status and in vitro fertilization potential in mature female mice. Vet Res Forum 2017; 8(4): 341-345.
  20. Bandariyan E, Mogheiseh A, Ahmadi A. The effect of lutein and Urtica dioica extract on in vitro production of embryo and oxidative status in polycystic ovary syndrome in a model of mice. BMC Complement Med Ther 2021; 21(1): 55. doi: 10.1186/s12906-021-03229-x.
  21. Mohammadi M. Oxidative stress and polycystic ovary syndrome: a brief review. Int J Prev Med 2019; 10: 86. doi: 10.4103/ijpvm.IJPVM57617.
  22. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, et al. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 2007; 18(7): 280-285.
  23. Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014; 2014: 360438. doi: 10.1155/ 2014/360438.
  24. Mizgier M, Jarząbek-Bielecka G, Wendland N, et al. Relation between inflammation, oxidative stress, and macronutrient intakes in normal and excessive bodyweight adolescent girls with clinical features of polycystic ovary syndrome. Nutrients 2021; 13(3): 896. doi: 10.3390/nu13030896.
  25. Shorakae S, Ranasinha S, Abell S, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol (Oxf) 2018; 89(5): 628-633.
  26. Sarawi WS, Alhusaini AM, Fadda LM, et al. Nano-curcumin prevents copper reproductive toxicity by attenuating oxidative stress and inflammation and improving Nrf2/HO-1 signaling and pituitary-gonadal axis in male rats. Toxics 2022; 10(7): 356. doi: 10.3390/toxics10070356.
  27. Bao X, Chen M, Yue Y, et al. Effects of dietary nano-curcumin supplementation on growth performance, glucose metabolism, and endoplasmic reticulum stress in juvenile largemouth bass, Micropterus salmoides. Front Mar Sci 2022; 9: 924569. doi: 10.3389/fmars. 2022.924569.
  28. Reddy PS, Begum N, Mutha S, et al. Beneficial effect of curcumin in letrozole induced polycystic ovary syndrome. Asian Pac J Reprod 2016; 5(2): 116-122.
  29. Louisa M, Wanafri E, Arozal W, et al. Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats. Pharm Biol 2023; 61(1): 298-305.